TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,264,639 | -9.0% | 390,507 | +170.3% | 0.08% | -12.8% |
| Q2 2023 | $3,589,007 | -21.5% | 144,485 | -62.6% | 0.09% | -27.7% |
| Q4 2022 | $4,571,905 | +2087.5% | 386,467 | +992.7% | 0.13% | +1757.1% |
| Q3 2022 | $209,000 | -54.7% | 35,369 | -14.8% | 0.01% | -74.1% |
| Q4 2019 | $461,000 | +62.9% | 41,522 | +92.9% | 0.03% | +35.0% |
| Q2 2018 | $283,000 | -76.8% | 21,522 | -75.0% | 0.02% | -76.5% |
| Q1 2018 | $1,220,000 | +121.4% | 85,943 | +27.8% | 0.08% | +41.7% |
| Q4 2017 | $551,000 | +108.7% | 67,243 | +54.2% | 0.06% | +71.4% |
| Q2 2016 | $264,000 | -7.7% | 43,609 | +82.1% | 0.04% | +40.0% |
| Q4 2015 | $286,000 | -44.9% | 23,950 | -23.5% | 0.02% | -56.9% |
| Q2 2015 | $519,000 | – | 31,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |